Upgrade to SI Premium - Free Trial

KaloBios Pharma (KBIO) on Watch Ahead of Shkreli Interview

November 24, 2015 11:47 AM
KaloBios Pharma (NASDAQ: KBIO) remains in focus ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Management Comments Momentum Movers Short Sales Trader Talk

Next Articles